The change of guards is also an apparent act of the management to maximise personal interests. I can only imagine the tension within the management team when all those free options expired last months while Richard collected a few millions in his pockets already.
sure if they deliver shareholder values, its their entitlement but hey - where are all those sophisticated investors or global pharmaceuticals???
- Forums
- ASX - By Stock
- NEU
- Ann: Temporary enrolment pause ended in Phase 3 trial in the US
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.33%
!
$13.15

Ann: Temporary enrolment pause ended in Phase 3 trial in the US, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.15 |
Change
0.300(2.33%) |
Mkt cap ! $1.635B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $4.625M | 352.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 86 | $13.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.15 | 171 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 402 | 13.150 |
6 | 444 | 13.140 |
8 | 697 | 13.130 |
4 | 651 | 13.120 |
8 | 1603 | 13.110 |
Price($) | Vol. | No. |
---|---|---|
13.160 | 581 | 4 |
13.170 | 598 | 7 |
13.180 | 975 | 7 |
13.190 | 1377 | 5 |
13.200 | 2353 | 8 |
Last trade - 12.47pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
SPONSORED BY The Market Online